|Day Low/High||2.70 / 2.84|
|52 Wk Low/High||2.28 / 4.50|
Combines Bacterin's Strength in Orthobiologics With X-spine's Expertise in Hardware Offering Complementary Product Lines Focused on Orthopedic and Spine Surgical Procedures
Second Quarter Total Revenue in the Range of $10.0 Million to $10.2 Million, an Increase of Approximately 12-15% Over the Same Period Last Year.
Company Continues to See Record Revenue Growth, Gross Profit Increases and Improved Gross Margins
First Quarter Total Revenue Expected to be in the Range of $9.4 Million to $9.5 Million, an Increase of Approximately 5-7% Over the Same Period Last Year